Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating constipation and application thereof

A technology for treating constipation and composition, which is applied in the direction of drug combination, medical raw materials derived from bacteria, and pharmaceutical formulations, etc. It can solve the problems of affecting the absorption of trace elements, increasing the burden on the patient's gastrointestinal tract, and increasing the volume of stool, so as to promote colonization Effect

Inactive Publication Date: 2013-01-09
李宁
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] A large amount of dietary fiber supplementation from the diet requires a considerable amount of food containing dietary fiber, which may increase the burden on the gastrointestinal tract of the patient, causing delayed gastric emptying, resulting in abdominal distension, epigastric discomfort, belching, loss of appetite, indigestion and other symptoms ; and includes a large amount of insoluble dietary fiber, which can increase the volume of stool, thereby increasing the burden on the intestinal tract, and excessive insoluble dietary fiber will affect the absorption of trace elements

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating constipation and application thereof
  • Pharmaceutical composition for treating constipation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Weigh the activity of commercially available strains to 10 8 CFU / g of Bacillus subtilis, Lactobacillus acidophilus and Lactobacillus bulgaricus each 0.5g to make mixed probiotics, with 20g inulin (commercially available) and 16g glutamine (commercially available) Mix well at -5~5℃ to make powder.

Embodiment 2

[0053] Weigh the activity of commercially available strains to 10 8 CFU / g of Bacillus subtilis, Lactobacillus acidophilus and Lactobacillus bulgaricus each 0.6g to make a mixed probiotic inoculum, and 25 g polydextrose (commercially available) and 18 g glutamine (commercially available ) Mix well at -5~5℃ to make powder.

Embodiment 3

[0055] Weigh the activity of commercially available strains to 10 8 CFU / g of Bacillus subtilis, Lactobacillus acidophilus, and Lactobacillus bulgaricus inoculum were each made into a mixed probiotic inoculum, with 15 g of isomalt oligosaccharide (commercially available) and 14 g of glutamine (commercially available). (Sale) After mixing uniformly at -5~5℃, it is made into powder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating constipation and application of the pharmaceutical composition. The pharmaceutical composition contains the following effective components in parts by weight: 10-30 parts of water-soluble dietary fiber, 10-20 parts of glutamine and 1-3 parts of mixed probiotics microbial inoculums consisting of bacillus subtilis, lactobacillus acidophilus and lactobacillus bulgaricus. The pharmaceutical composition has the efficacies of softening excrement, promoting intestine peristalsis, restoring intestinal flora balance, repairing impaired intestinal mucosa, restoring the normal physiological function of intestinal tracts, and treating constipation fundamentally. The components of the composition achieve respective effects to alleviate constipation symptoms, and promote mutually and cooperate with each other to enhance curative effects, and the use effect of the pharmaceutical composition is obviously better than single use of each component.

Description

Technical field [0001] The invention belongs to the field of pharmacy, and specifically relates to a pharmaceutical composition for treating constipation and its application. Background technique [0002] Constipation is a group of symptoms characterized by decreased bowel frequency, difficulty in defecation or incomplete defecation, dry stool, and hard stool. It is a very common clinical symptom. The incidence of constipation in western countries is about 6%-28%. The prevalence is between 3%-17.6%. Long-term constipation seriously affects the health and quality of life of patients, and can lead to complications such as hemorrhoids, anal fissure, and colon cancer. [0003] At present, most patients with constipation mainly use various laxatives to relieve their symptoms, but laxatives generally cause diarrhea in a short period of time, long-term use has large side effects, and can lead to laxative dependence, which can aggravate constipation after stopping the drug. [0004] At pre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/74A61P1/10A61K35/742A61K35/747
Inventor 李宁虞文魁姜军陈启仪沈娟红韦瑶
Owner 李宁
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products